See our Coronavirus Product Pipeline
The Native Antigen Company is developing an extensive range of antigens and antibodies for the human coronaviruses, including SARS-CoV-2 (COVID-19).
New Antigen and Antibody Conjugation Kits
The Native Antigen Company now offers a range of antigen and antibody conjugation kits that use a novel chemistry to generate highly reproducible protein conjugates.
SARS-CoV-2 S1 and S2 Antigens Now Available
The Native Antigen Company is now offering recombinant S1 and S2 glycoproteins for SARS-CoV-2 (COVID-19) in response to urgent demand.
About The Native Antigen Company
The Native Antigen Company specialises in the development and manufacture of native and recombinant viral and bacterial antigens, antibodies and immunoassays, as well as bespoke product development and custom manufacturing. The company has decades of experience in producing high-quality proteins with its proprietary mammalian cell expression system to ensure correct glycosylation and proper folding. The Native Antigen Company’s high-quality reagents are widely adopted by leading pharmaceutical, in vitro diagnostic assay manufacturers, and academic groups in cutting-edge vaccine research and serology, where correct folding and glycosylation are vital.